GlobalDeal

Mannkind

Biotechnology · Danbury, United Kingdom

mannkind.com

About Mannkind

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products for diabetes and other endocrine disorders. The company is best known for its inhaled insulin product, Afrezza, which is designed to improve glycemic control in adults with diabetes. MannKind aims to leverage its proprietary Technosphere® platform to develop additional products that can enhance patient outcomes and provide alternatives to traditional therapies. With a commitment to research and development, MannKind is dedicated to addressing unmet medical needs in the diabetes space and beyond.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Diabetes Care, Inhalation Therapy, Drug Development, Medical Devices
Location
Danbury, United Kingdom
Employees
51–200
Founded
2018

Products and services

Open Mannkind in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United Kingdom

All 2,199 Biotechnology companies in United Kingdom →